Occlusion Patch Adhesive Activation and Detachment Mechanism

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing occlusive devices for cardiovascular defects require an extended period for patch attachment and removal, making procedures inconvenient and prone to complications like thrombosis or infection.

Innovation Solution

The method involves using an inactive adhesive on the occlusion patch that activates upon contact with cardiac tissue or employing a detachment mechanism in the balloon catheter for immediate release, allowing for accelerated attachment and release of the patch, respectively, using bio-degradable materials that are metabolized or eroded over time.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a metallic frame is used to provide permanent support for the occlusion device, then the device can maintain its position on the cardiac structure, but the patient is exposed to risks including wire fractures, perforations, and potential leaching of toxic materials

Engineering Contradiction:
Improvedevice position stabilityVSAvoidtoxic material leaching and wire fractures
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent removes the metallic frame component from the occlusion device, extracting the harmful element while retaining the essential occlusion function through an all-polymer construction that eliminates toxic material leaching and wire fracture risks

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs composite polymeric materials including shape memory polymers and self-hardening polymers to create a device that provides structural support and positional stability without metallic components, achieving both reliability and biocompatibility

Inventive Principle:
Principle #40Composite materials

2Reliability

If the patch is attached using coagulation/endothelialization process, then the patch adheres to the cardiac tissue, but the procedure requires an extended period of time which makes it inconvenient and prone to complications

Engineering Contradiction:
Improvepatch attachment stabilityVSAvoidprocedure duration
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies adhesive to the patch before delivery to the patient, performing the attachment preparation in advance so that when the patch is positioned, attachment occurs immediately upon contact with cardiac tissue, eliminating the extended waiting period

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent changes the chemical state of the adhesive from inactive to active through exposure to bodily fluids or specific triggers, enabling rapid activation of the attachment process at the desired location and time, reducing procedure duration while maintaining reliable adhesion

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If the adhesive is applied in inactive form to the patch, then the patch can be delivered and positioned correctly, but the adhesive must be activated after placement to ensure proper attachment

Engineering Contradiction:
Improvedevice delivery and positioningVSAvoidadhesive activation mechanism
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent designs the adhesive to automatically activate through self-service mechanisms such as exposure to bodily fluids, pH changes, or temperature variations in the implantation site, eliminating the need for external activation equipment or complex control systems

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent uses bodily fluids or environmental conditions at the implantation site as intermediaries to trigger adhesive activation, allowing the biological environment itself to serve as the activation mechanism without adding device complexity

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables convenient outpatient procedures with reduced complications, facilitating quicker defect correction and minimizing risks associated with metallic devices.

Implementation Method 1

an inactive adhesive on the occlusion patch that activates upon contact with cardiac tissue

Methodology Applied
Scientific EffectAdhesive activation: Adhesive

Implementation Method 2

using bio-degradable materials that are metabolized or eroded over time

Methodology Applied
Scientific EffectBiodegradation: Decomposition (biological)

Data Source

PatentUS9770234B2Method and apparatus for occluding a physiological opening
Publication Date: 2017.09.26 SIDERIS ELEFTHERIOS B
  • US9770234B2 patent drawing
  • US9770234B2 patent drawing
  • US9770234B2 patent drawing

AI summary

A method and apparatus for suture-less placement of an occluding patch in which release of the device can be accelerated. In one embodiment, an inactive form of an adhesive is applied on the area of the patch that will come into contact with cardiac tissue; this allows for the introduction and necessary manipulation of the catheter system until activation of the adhesive occurs. In accordance with one aspect of the invention, the adhesive properties of certain polymeric materials are relied upon rather than their ability to cure or harden into a specific shape. In another embodiment, the patch is immediately released utilizing a detaching mechanism on the balloon or the balloon catheter which supports the patch; the patch along with the inflated balloon remain on the cardiac structure occluding the opening.